Market Analysis and Insights: Global Aurora Kinase B Market
The global Aurora Kinase B market is valued at US$ XX million in 2019. The market size will reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.

Global Aurora Kinase B Scope and Market Size
Aurora Kinase B market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Aurora Kinase B market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
AZD-2811
CS-2164
Danusertib
Ilorasertib
NMI-900
Others

Segment by Application
Anaplastic Large Cell Lymphoma
Kidney Cancer
Lung Cancer
Prostate Cancer
Others

By Company
AbbVie Inc
Advenchen Laboratories LLC
Aeterna Zentaris Inc
Amgen Inc
AstraZeneca Plc
Chipscreen Biosciences Ltd
Cielo Therapeutics Inc
Sanofi
Sareum Holdings Plc

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia